$170.61
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Globe Life, Inc. is an insurance holding company, which engages in the provision of individual life and supplemental health insurance products and services. The company is headquartered in Mckinney, Texas and currently employs 3,695 full-time employees. Its primary subsidiaries are Globe Life And Accident Insurance Company, American Income Life Insurance Company, Liberty National Life Insurance Company, Family Heritage Life Insurance Company of America, and United American Insurance Company. The Company’s segments include life insurance, supplemental health insurance, and investments. Life insurance products include traditional whole life and term life insurance. The firm offers Medicare Supplement and limited-benefit supplemental health insurance products that include accident, cancer, critical illness, heart, intensive care, and other health products. These products are designed to supplement health coverage that applicants already own. Medicare Supplements are offered to enrollees in the traditional fee-for-service Medicare program. Medicare Supplement plans are standardized by federal regulation and are designed to pay deductibles and co-payments not paid by Medicare.
Country

US

CEO

Mr. J. Matthew Darden

IPO date

1980

Employees

3,695

ISIN

US37959E1029

Key stats

Open

$170.20

Volume

350.12K

Market cap

$13.10B

Prev. close

$170.49

Impl / hst vl

-

Open interest

$0.00

$169.81

Day’s Range

$173.51

$135.07

52W Range

$191.55

Valuation

55
Valuation score
Fairly Valued
P/E
11.49
P/S
2.25
P/B
2.26
Current ratio
0.70
Debt / Equity
0.48
ROE
20.28%
Gross margin
-
Income growth
6.37%
FCF growth
-24.86

Oct

30

Dividends

The next payment date will be Oct 30, 2026

Div. per Share

$0.33

Div. Yield

0.19%

Payout Ratio

-

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Buy

The average rating from top 14 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$193.72
The top 17 analysts forecasts that 12-month price may increase by 13.54%, with a low of $151.50 and a high of $236.25
$151.50
Low
$193.72
Avg
$236.25
High
Current price

Earnings

Q2 ‘26 revenue
$1.60B
Q2 ‘26 net income
$287.75M
Revenue
Net income
Previous EPS
$3.43
Estimate EPS
$3.79
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply